What is the Nipah virus? Oxford begins testing
by Nuray Bulbul and Ayan Omar
Jan 11, 2024
2 minutes
The University of Oxford announced today that the first ever human trial for an experimental vaccine against the deadly Nipah virus is underway.
Around 51 people aged 18-55 will take part in the trial, which will be led by the Oxford Vaccine Group and is funded by the Coalition for Epidemic Preparedness Innovations (CEPI).
The first participants in the trial received doses of the vaccine over the past week.
You’re reading a preview, subscribe to read more.
Start your free 30 days